Welcome to an emerging world of exoskeletons, digital twins, and V2X (vehicle-to-everything) technology, shaped by research ...
Nxera Pharma Co. Ltd (“Nxera” or “the Company; TSE 4565) today announces that Boehringer Ingelheim has informed the Company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback